Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 297-302 , November 2005

Tracking Stem Cells in the Cardiovascular System

References 

  1. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005;23:983–987
  2. Aime S, Barge A, Cabella C, et al. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. [Review] [46 Refs] Curr. Pharm. Biotechnol. 2004;5:509–518
  3. Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004;104:1217–1223
  4. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation. 2003;108:863–868
  5. Bogdanov A, Matuszewski L, Bremer C, et al. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol. Imaging. 2002;1:16–23
  6. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–2218
  7. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001;19:1141–1147
  8. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol. 2004;386:275–299
  9. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood. 2004;104:3410–3412[author reply 3412-3413]
  10. Chance B. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann. N. Y. Acad. Sci. 1998;838:29–45
  11. Chemaly E, Gianni D, Lebeche D, et al. Tracking and gene expression profile of bone marrow mesenchymal stem cells injected into pig myocardium. In: 2nd Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences July:24-27. Keystone, CO, USA. 2005;
  12. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766–2771
  13. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760–767
  14. Ding W, Bai J, Zhang J, et al. In vivo tracking of implanted stem cells using radio-labeled transferrin scintigraphy. Nucl Med Biol. 2004;31:719–725
  15. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 2004;110:3378–3383
  16. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging?. J. Am. Coll. Cardiol. 2004;43:1325–1327
  17. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–419
  18. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009–1014
  19. Klibanov AL, Rasche PT, Hughes MS, et al. Detection of individual microbubbles of ultrasound contrast agents: Imaging of free-floating and targeted bubbles. Invest. Radiol. 2004;39:187–195
  20. Kostura L, Kraitchman DL, Mackay AM, et al. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17:513–517
  21. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290–2293
  22. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000;18:410–414
  23. Liang HD, Blomley MJ. The role of ultrasound in molecular imaging. Br. J. Radiol. 2003;76(Spec No 2):S140–S150
  24. MacLaren DC, Toyokuni T, Cherry SR, et al. PET imaging of transgene expression. Biol. Psychiatry. 2000;48:337–348
  25. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J. Am. Coll. Cardiol. 2004;43:1315–1324
  26. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. [Review] [82 Refs] Science. 2005;307:538–544
  27. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002;17:803–811
  28. Modo M, Mellodew K, Cash D, et al. Mapping transplanted stem cell migration after a stroke: A serial, in vivo magnetic resonance imaging study. Neuroimage. 2004;21:311–317
  29. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 2005;16:89–92
  30. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705
  31. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–2302
  32. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 2004;95:9–20
  33. Roguin A, Donahue JK, Bomma CS, et al. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin. Electrophysiol. 2005;28:336–338
  34. Rudin M, Rausch M, Stoeckli M. Molecular imaging in drug discovery and development: Potential and limitations of nonnuclear methods. Mol. Imaging Biol. 2005;7:5–13
  35. Saito T, Kuang JQ, Lin CC, et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J. Thorac. Cardiovasc. Surg. 2003;126:114–123
  36. Simon GH, Raatschen HJ, Wendland MF, et al. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: Original research. Acad. Radiol. 2005;[Electronic publication ahead of print]
  37. Simonova M, Shtanko O, Sergeyev N, et al. Engineering of Technetium-99m-binding artificial receptors for imaging gene expression. J. Gene Med. 2003;5:1056–1066
  38. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918
  39. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation. 2003;107:1092–1095
  40. Wong MH, Saam JR, Stappenbeck TS, et al. Genetic mosaic analysis based on Cre recombinase and navigated laser capture microdissection. Proc. Natl. Acad. Sci. U. S. A. 2000;97:12601–12606
  41. Wu JC, Chen IY, Sundaresan G, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 2003;108:1302–1305
  42. Yoneyama R, Pomerantseva I, Kawase Y, et al. Magnetic resonance imaging of ferumoxide labeled mesenchymal stem cells in myocardium injected by catheter-based technique via coronary vein. In: The Tony and Shelly Malkin stem cell symposium November 8. Boston, MA, USA. 2004;

PII: S1050-1738(05)00180-5

doi: 10.1016/j.tcm.2005.09.004

Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 297-302 , November 2005

Article Tools

* Image Usage & Resolution